IL-33 enhances retinoic acid signaling on CD4+T cells
Author
dc.contributor.author
Gajardo, Tania
Author
dc.contributor.author
Pérez, Francisco
Author
dc.contributor.author
Terraza, Claudia
Author
dc.contributor.author
Campos Mora, Mauricio
Author
dc.contributor.author
Noelle, Randolph J.
Author
dc.contributor.author
Pino Lagos, Karina
Admission date
dc.date.accessioned
2016-12-19T20:31:58Z
Available date
dc.date.available
2016-12-19T20:31:58Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Cytokine 85 (2016) 120–122
es_ES
Identifier
dc.identifier.other
10.1016/j.cyto.2016.06.016
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/141986
Abstract
dc.description.abstract
Several molecules have been described as CD4+ T cells differentiation modulators and among them retinoic acid (RA) and more recently, IL-33, have been studied. Due to the similarities in T helper cell skewing properties between RA and IL-33, we asked whether IL-33 intersects, directly or indirectly, the RA signaling pathway. Total CD4+ T cells from DR5-luciferase mice were activated in the presence of RA with or without IL-33, and RA signaling was visualized using ex vivo imaging. Our results demonstrate that IL-33 itself is able to trigger RA signaling on CD4+ T cells, which is highly increased when IL-33 is added in conjunction with RA. This study presents IL-33 as a potential player that may synergize with RA in controlling T cell differentiation, and suggests that IL-33 may be an attractive target in controlling T cell differentiation in vivo.